| UniProt ID | STIM1_HUMAN | |
|---|---|---|
| UniProt AC | Q13586 | |
| Protein Name | Stromal interaction molecule 1 | |
| Gene Name | STIM1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 685 | |
| Subcellular Localization |
Cell membrane Single-pass type I membrane protein . Endoplasmic reticulum membrane Single-pass type I membrane protein . Cytoplasm, cytoskeleton . Sarcoplasmic reticulum . Translocates from the endoplasmic reticulum to the cell membrane in response |
|
| Protein Description | Plays a role in mediating store-operated Ca(2+) entry (SOCE), a Ca(2+) influx following depletion of intracellular Ca(2+) stores. [PubMed: 15866891] | |
| Protein Sequence | MDVCVRLALWLLWGLLLHQGQSLSHSHSEKATGTSSGANSEESTAAEFCRIDKPLCHSEDEKLSFEAVRNIHKLMDDDANGDVDVEESDEFLREDLNYHDPTVKHSTFHGEDKLISVEDLWKAWKSSEVYNWTVDEVVQWLITYVELPQYEETFRKLQLSGHAMPRLAVTNTTMTGTVLKMTDRSHRQKLQLKALDTVLFGPPLLTRHNHLKDFMLVVSIVIGVGGCWFAYIQNRYSKEHMKKMMKDLEGLHRAEQSLHDLQERLHKAQEEHRTVEVEKVHLEKKLRDEINLAKQEAQRLKELREGTENERSRQKYAEEELEQVREALRKAEKELESHSSWYAPEALQKWLQLTHEVEVQYYNIKKQNAEKQLLVAKEGAEKIKKKRNTLFGTFHVAHSSSLDDVDHKILTAKQALSEVTAALRERLHRWQQIEILCGFQIVNNPGIHSLVAALNIDPSWMGSTRPNPAHFIMTDDVDDMDEEIVSPLSMQSPSLQSSVRQRLTEPQHGLGSQRDLTHSDSESSLHMSDRQRVAPKPPQMSRAADEALNAMTSNGSHRLIEGVHPGSLVEKLPDSPALAKKALLALNHGLDKAHSLMELSPSAPPGGSPHLDSSRSHSPSSPDPDTPSPVGDSRALQASRNTRIPHLAGKKAVAEEDNGSIGEETDSSPGRKKFPLKIFKKPLKK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 34 | O-linked_Glycosylation | HSEKATGTSSGANSE CCCCCCCCCCCCCCC | 18.50 | OGP | |
| 35 | O-linked_Glycosylation | SEKATGTSSGANSEE CCCCCCCCCCCCCCC | 28.28 | OGP | |
| 40 | Phosphorylation | GTSSGANSEESTAAE CCCCCCCCCCCHHHH | 42.05 | 28857561 | |
| 44 | O-linked_Glycosylation | GANSEESTAAEFCRI CCCCCCCHHHHHHCC | 32.92 | OGP | |
| 53 | Acetylation | AEFCRIDKPLCHSED HHHHCCCCCCCCCCC | 37.20 | 26822725 | |
| 56 | Glutathionylation | CRIDKPLCHSEDEKL HCCCCCCCCCCCCCC | 4.50 | 22833525 | |
| 126 | Phosphorylation | DLWKAWKSSEVYNWT HHHHHHHCCCCCCCC | 22.49 | 24043423 | |
| 127 | Phosphorylation | LWKAWKSSEVYNWTV HHHHHHCCCCCCCCH | 27.62 | 24043423 | |
| 130 | Phosphorylation | AWKSSEVYNWTVDEV HHHCCCCCCCCHHHH | 10.84 | 24043423 | |
| 131 | N-linked_Glycosylation | WKSSEVYNWTVDEVV HHCCCCCCCCHHHHH | 32.87 | 11983428 | |
| 131 | N-linked_Glycosylation | WKSSEVYNWTVDEVV HHCCCCCCCCHHHHH | 32.87 | 11983428 | |
| 133 | Phosphorylation | SSEVYNWTVDEVVQW CCCCCCCCHHHHHHH | 17.91 | 24043423 | |
| 143 | Phosphorylation | EVVQWLITYVELPQY HHHHHHHHHHCCHHH | 21.24 | 24043423 | |
| 144 | Phosphorylation | VVQWLITYVELPQYE HHHHHHHHHCCHHHH | 5.73 | 24043423 | |
| 150 | Phosphorylation | TYVELPQYEETFRKL HHHCCHHHHHHHHHH | 17.50 | 24043423 | |
| 153 | Phosphorylation | ELPQYEETFRKLQLS CCHHHHHHHHHHHHC | 19.46 | 24043423 | |
| 156 | Ubiquitination | QYEETFRKLQLSGHA HHHHHHHHHHHCCCC | 36.07 | - | |
| 170 | O-linked_Glycosylation | AMPRLAVTNTTMTGT CCCEEEEECCCCCEE | 22.65 | 30059200 | |
| 171 | N-linked_Glycosylation | MPRLAVTNTTMTGTV CCEEEEECCCCCEEE | 27.27 | 8707854 | |
| 171 | N-linked_Glycosylation | MPRLAVTNTTMTGTV CCEEEEECCCCCEEE | 27.27 | 8707854 | |
| 175 | Phosphorylation | AVTNTTMTGTVLKMT EEECCCCCEEEEECC | 27.84 | 26552605 | |
| 177 | Phosphorylation | TNTTMTGTVLKMTDR ECCCCCEEEEECCCC | 17.31 | 26552605 | |
| 182 | Phosphorylation | TGTVLKMTDRSHRQK CEEEEECCCCHHHHH | 27.03 | 26552605 | |
| 185 | Phosphorylation | VLKMTDRSHRQKLQL EEECCCCHHHHHHHH | 26.32 | 26552605 | |
| 236 | Phosphorylation | FAYIQNRYSKEHMKK HHHHHHHCCHHHHHH | 31.48 | - | |
| 246 | Ubiquitination | EHMKKMMKDLEGLHR HHHHHHHHHHHHHHH | 56.51 | - | |
| 246 | Malonylation | EHMKKMMKDLEGLHR HHHHHHHHHHHHHHH | 56.51 | 26320211 | |
| 257 | Phosphorylation | GLHRAEQSLHDLQER HHHHHHHHHHHHHHH | 21.12 | 29255136 | |
| 267 | Ubiquitination | DLQERLHKAQEEHRT HHHHHHHHHHHHHCC | 57.25 | 21906983 | |
| 279 | 2-Hydroxyisobutyrylation | HRTVEVEKVHLEKKL HCCEEEEHHHHHHHH | 39.88 | - | |
| 279 | Ubiquitination | HRTVEVEKVHLEKKL HCCEEEEHHHHHHHH | 39.88 | - | |
| 285 | Ubiquitination | EKVHLEKKLRDEINL EHHHHHHHHHHHHHH | 39.10 | - | |
| 294 | Ubiquitination | RDEINLAKQEAQRLK HHHHHHHHHHHHHHH | 52.41 | - | |
| 315 | Ubiquitination | ENERSRQKYAEEELE CCHHHHHHHHHHHHH | 45.37 | - | |
| 330 | Ubiquitination | QVREALRKAEKELES HHHHHHHHHHHHHHH | 62.84 | - | |
| 333 | Ubiquitination | EALRKAEKELESHSS HHHHHHHHHHHHCCC | 72.89 | - | |
| 337 | Phosphorylation | KAEKELESHSSWYAP HHHHHHHHCCCCCCH | 41.09 | 23403867 | |
| 339 | Phosphorylation | EKELESHSSWYAPEA HHHHHHCCCCCCHHH | 31.67 | 23403867 | |
| 340 | Phosphorylation | KELESHSSWYAPEAL HHHHHCCCCCCHHHH | 20.77 | 23403867 | |
| 342 | Phosphorylation | LESHSSWYAPEALQK HHHCCCCCCHHHHHH | 17.77 | 23403867 | |
| 361 | Phosphorylation | THEVEVQYYNIKKQN HHHHEEEEEECCCCC | 12.03 | - | |
| 371 | Ubiquitination | IKKQNAEKQLLVAKE CCCCCHHHEEEHHHH | 43.78 | - | |
| 377 | Ubiquitination | EKQLLVAKEGAEKIK HHEEEHHHHHHHHHH | 49.56 | - | |
| 377 | Acetylation | EKQLLVAKEGAEKIK HHEEEHHHHHHHHHH | 49.56 | 25953088 | |
| 389 | Phosphorylation | KIKKKRNTLFGTFHV HHHHHHCCCEEEEEE | 27.74 | 27251275 | |
| 393 | Phosphorylation | KRNTLFGTFHVAHSS HHCCCEEEEEECCCC | 11.84 | 30108239 | |
| 399 | Phosphorylation | GTFHVAHSSSLDDVD EEEEECCCCCCHHCC | 16.34 | 30108239 | |
| 400 | Phosphorylation | TFHVAHSSSLDDVDH EEEECCCCCCHHCCH | 25.67 | 30108239 | |
| 401 | Phosphorylation | FHVAHSSSLDDVDHK EEECCCCCCHHCCHH | 38.54 | 30108239 | |
| 413 | Ubiquitination | DHKILTAKQALSEVT CHHHHHHHHHHHHHH | 30.76 | 2190698 | |
| 420 | Phosphorylation | KQALSEVTAALRERL HHHHHHHHHHHHHHH | 11.36 | 22817900 | |
| 486 | Phosphorylation | DMDEEIVSPLSMQSP CCCHHHCCCHHCCCH | 26.28 | 22817900 | |
| 492 | Phosphorylation | VSPLSMQSPSLQSSV CCCHHCCCHHHHHHH | 14.07 | 22817900 | |
| 498 | Phosphorylation | QSPSLQSSVRQRLTE CCHHHHHHHHHHHCC | 14.36 | 24275569 | |
| 504 | Phosphorylation | SSVRQRLTEPQHGLG HHHHHHHCCCCCCCC | 48.05 | 24702127 | |
| 512 | Phosphorylation | EPQHGLGSQRDLTHS CCCCCCCCCCCCCCC | 27.38 | 23401153 | |
| 517 | Phosphorylation | LGSQRDLTHSDSESS CCCCCCCCCCCCCCC | 24.51 | 29255136 | |
| 519 | Phosphorylation | SQRDLTHSDSESSLH CCCCCCCCCCCCCCC | 37.28 | 29255136 | |
| 521 | Phosphorylation | RDLTHSDSESSLHMS CCCCCCCCCCCCCCC | 42.25 | 29255136 | |
| 523 | Phosphorylation | LTHSDSESSLHMSDR CCCCCCCCCCCCCCC | 42.00 | 29255136 | |
| 524 | Phosphorylation | THSDSESSLHMSDRQ CCCCCCCCCCCCCCC | 20.45 | 29255136 | |
| 527 | Sulfoxidation | DSESSLHMSDRQRVA CCCCCCCCCCCCCCC | 5.59 | 21406390 | |
| 528 | Phosphorylation | SESSLHMSDRQRVAP CCCCCCCCCCCCCCC | 20.92 | 23401153 | |
| 541 | Phosphorylation | APKPPQMSRAADEAL CCCCCCHHHHHHHHH | 17.33 | 26437602 | |
| 551 | Sulfoxidation | ADEALNAMTSNGSHR HHHHHHHHCCCCCCC | 4.03 | 21406390 | |
| 553 | Phosphorylation | EALNAMTSNGSHRLI HHHHHHCCCCCCCCE | 26.55 | 19881501 | |
| 556 | Phosphorylation | NAMTSNGSHRLIEGV HHHCCCCCCCCEECC | 15.08 | - | |
| 567 | Phosphorylation | IEGVHPGSLVEKLPD EECCCCCCHHHHCCC | 33.42 | 23927012 | |
| 575 | Phosphorylation | LVEKLPDSPALAKKA HHHHCCCCHHHHHHH | 15.33 | 19664994 | |
| 580 | Acetylation | PDSPALAKKALLALN CCCHHHHHHHHHHHH | 39.15 | 25953088 | |
| 581 | Ubiquitination | DSPALAKKALLALNH CCHHHHHHHHHHHHC | 38.36 | - | |
| 595 | Phosphorylation | HGLDKAHSLMELSPS CCHHHHHHHHHHCCC | 33.98 | 23401153 | |
| 600 | Phosphorylation | AHSLMELSPSAPPGG HHHHHHHCCCCCCCC | 11.96 | 30266825 | |
| 602 | Phosphorylation | SLMELSPSAPPGGSP HHHHHCCCCCCCCCC | 50.46 | 30266825 | |
| 608 | Phosphorylation | PSAPPGGSPHLDSSR CCCCCCCCCCCCCCC | 18.30 | 29255136 | |
| 613 | Phosphorylation | GGSPHLDSSRSHSPS CCCCCCCCCCCCCCC | 33.73 | 30266825 | |
| 614 | Phosphorylation | GSPHLDSSRSHSPSS CCCCCCCCCCCCCCC | 37.15 | 30266825 | |
| 616 | Phosphorylation | PHLDSSRSHSPSSPD CCCCCCCCCCCCCCC | 30.20 | 29255136 | |
| 618 | Phosphorylation | LDSSRSHSPSSPDPD CCCCCCCCCCCCCCC | 27.94 | 29255136 | |
| 620 | Phosphorylation | SSRSHSPSSPDPDTP CCCCCCCCCCCCCCC | 58.48 | 29255136 | |
| 621 | Phosphorylation | SRSHSPSSPDPDTPS CCCCCCCCCCCCCCC | 36.38 | 22167270 | |
| 626 | Phosphorylation | PSSPDPDTPSPVGDS CCCCCCCCCCCCCCH | 30.93 | 23927012 | |
| 628 | Phosphorylation | SPDPDTPSPVGDSRA CCCCCCCCCCCCHHH | 34.02 | 23927012 | |
| 633 | Phosphorylation | TPSPVGDSRALQASR CCCCCCCHHHHHHHC | 17.33 | 23927012 | |
| 650 | Acetylation | RIPHLAGKKAVAEED CCCHHHCCCCEEECC | 31.77 | 25953088 | |
| 660 | Phosphorylation | VAEEDNGSIGEETDS EEECCCCCCCCCCCC | 33.40 | 29255136 | |
| 665 | Phosphorylation | NGSIGEETDSSPGRK CCCCCCCCCCCCCCC | 36.56 | 29255136 | |
| 667 | Phosphorylation | SIGEETDSSPGRKKF CCCCCCCCCCCCCCC | 45.94 | 29255136 | |
| 668 | Phosphorylation | IGEETDSSPGRKKFP CCCCCCCCCCCCCCC | 33.90 | 29255136 | |
| 677 | Ubiquitination | GRKKFPLKIFKKPLK CCCCCCCCCCCCCCC | 46.46 | - | |
| 680 | Acetylation | KFPLKIFKKPLKK-- CCCCCCCCCCCCC-- | 57.88 | 70559 | |
| 681 | Acetylation | FPLKIFKKPLKK--- CCCCCCCCCCCC--- | 44.85 | 7354891 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 257 | S | Phosphorylation | Kinase | AMPKB1 | Q9Y478 | PSP |
| 257 | S | Phosphorylation | Kinase | AMPKG2 | Q9UGJ0 | PSP |
| 257 | S | Phosphorylation | Kinase | AMPKA1 | Q13131 | PSP |
| 361 | Y | Phosphorylation | Kinase | PYK2 | Q14289 | PSP |
| 389 | T | Phosphorylation | Kinase | PKACA | P17612 | PSP |
| 521 | S | Phosphorylation | Kinase | AMPKB1 | Q9Y478 | PSP |
| 521 | S | Phosphorylation | Kinase | AMPKG2 | Q9UGJ0 | PSP |
| 521 | S | Phosphorylation | Kinase | AMPKA1 | Q13131 | PSP |
| 575 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
| 608 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
| 621 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
| 668 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| - | K | Ubiquitination | E3 ubiquitin ligase | X | P03165 | PMID:32235678 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of STIM1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of STIM1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| STIM2_HUMAN | STIM2 | physical | 11463338 | |
| MARE1_HUMAN | MAPRE1 | physical | 23698468 | |
| EXOC5_HUMAN | EXOC5 | physical | 27173435 |
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-171, AND MASSSPECTROMETRY. | |
| "Elucidation of N-glycosylation sites on human platelet proteins: aglycoproteomic approach."; Lewandrowski U., Moebius J., Walter U., Sickmann A.; Mol. Cell. Proteomics 5:226-233(2006). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-171, AND MASSSPECTROMETRY. | |
| "Identification and quantification of N-linked glycoproteins usinghydrazide chemistry, stable isotope labeling and mass spectrometry."; Zhang H., Li X.-J., Martin D.B., Aebersold R.; Nat. Biotechnol. 21:660-666(2003). Cited for: GLYCOSYLATION AT ASN-171. | |
| "Stromal interaction molecule 1 (STIM1), a transmembrane protein withgrowth suppressor activity, contains an extracellular SAM domainmodified by N-linked glycosylation."; Williams R.T., Senior P.V., van Stekelenburg L., Layton J.E.,Smith P.J., Dziadek M.A.; Biochim. Biophys. Acta 1596:131-137(2002). Cited for: SUBUNIT, AND GLYCOSYLATION AT ASN-131 AND ASN-171. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-575; SER-660; THR-665AND SER-668, AND MASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-575, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-575; SER-608; SER-660AND SER-668, AND MASS SPECTROMETRY. | |
| "Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment."; Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.; J. Proteome Res. 7:5167-5176(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-257, AND MASSSPECTROMETRY. | |
| "Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-575, AND MASSSPECTROMETRY. | |
| "Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-575, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-575 AND SER-608, ANDMASS SPECTROMETRY. | |
| "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-420, AND MASSSPECTROMETRY. | |